The legalization of Marijuana is inevitable, the horses are out of the barn. If you travel to Colorado,California or British Columbia you will find store fronts where you can buy a variety of cannabis strains,smoking paraphernalia or a baseball hat with a pot leaf. These smaller storefronts also have delivery services similar to pizza parlors which is a big part of their business. This transition begs the question about when and how big tobacco will enter the market and it may be through established device manufacturers who regulate dosage.
Cigarette giant Philip Morris International will invest about $20 million in an Israeli start-up that developed a metered-dose vaporiser of raw plants for medical use, Israeli news website Calcalist reported on Tuesday. As part of the deal, Tel Aviv-based Syqe Medical will develop technologies for Phillip Morris that will help reduce health risks associated with smoking, Calcalist said, but provided no further details.
Officials at Syqe would not comment on the report and officials at Philip Morris could not be reached for immediate comment. Syqe, which was formed in 2011, says it has already developed an inhaler that allows medical cannabis to be delivered in a safe and precise manner. The technology turns cannabis into a granulate and allows it to be taken in standardized doses, Syqe says. The company plans to develop similar systems that can be used with other medicinal plants.
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer